Cargando…

Clinical Relevance of Right Atrial Functional Response to Treatment in Pulmonary Arterial Hypertension

Background: Right atrial (RA) function has emerged as an important determinant of outcome in pulmonary arterial hypertension (PAH). However, studies exploring RA function after initiation of specific pulmonary vascular treatment and its association with outcome in patients with incident PAH are lack...

Descripción completa

Detalles Bibliográficos
Autores principales:	Richter, Manuel J., Zedler, Daniel, Berliner, Dominik, Douschan, Philipp, Gall, Henning, Ghofrani, Hossein A., Kimmig, Lucas, Kremer, Nils, Olsson, Karen M., Brita da Rocha, Bruno, Rosenkranz, Stephan, Seeger, Werner, Yogeswaran, Athiththan, Rako, Zvonimir, Tello, Khodr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688770/ https://www.ncbi.nlm.nih.gov/pubmed/34950716 http://dx.doi.org/10.3389/fcvm.2021.775039

Ejemplares similares

Hepatorenal dysfunction in patients with chronic thromboembolic pulmonary hypertension
por: Yogeswaran, Athiththan, et al.
Publicado: (2023)

Echocardiographic pressure–strain loop‐derived stroke work of the right ventricle: validation against the gold standard
por: Richter, Manuel J., et al.
Publicado: (2023)

Adaptive versus maladaptive right ventricular remodelling
por: Rako, Zvonimir A., et al.
Publicado: (2022)

Estimated plasma volume status: association with congestion, cardiorenal syndrome and prognosis in precapillary pulmonary hypertension
por: Yogeswaran, Athiththan, et al.
Publicado: (2023)

Relevance of Cor Pulmonale in COPD With and Without Pulmonary Hypertension: A Retrospective Cohort Study
por: Yogeswaran, Athiththan, et al.
Publicado: (2022)

Echocardiographic evaluation of right ventricular diastolic function in pulmonary hypertension
por: Yogeswaran, Athiththan, et al.
Publicado: (2023)

Advanced risk stratification of intermediate risk group in pulmonary arterial hypertension
por: Yogeswaran, Athiththan, et al.
Publicado: (2020)

Validity of echocardiographic tricuspid regurgitation gradient to screen for new definition of pulmonary hypertension
por: Gall, Henning, et al.
Publicado: (2021)

Acute response to rapid iloprost inhalation using the Breelib™ nebulizer in pulmonary arterial hypertension: the Breelib™ acute study
por: Richter, Manuel J., et al.
Publicado: (2019)

Impact of SARS-CoV-2 pandemic on pulmonary hypertension out-patient clinics in Germany: a multi-centre study
por: Yogeswaran, Athiththan, et al.
Publicado: (2020)

Heart rate response during 6-minute walking testing predicts outcome in operable chronic thromboembolic pulmonary hypertension
por: Richter, Manuel Jonas, et al.
Publicado: (2016)

Thin Air Resulting in High Pressure: Mountain Sickness and Hypoxia-Induced Pulmonary Hypertension
por: Grimminger, Jan, et al.
Publicado: (2017)

Reply to Vanderpool et al.
por: Kremer, Nils, et al.
Publicado: (2023)

Long-term comprehensive cardiopulmonary phenotyping of COVID-19
por: Kimmig, Lucas M., et al.
Publicado: (2022)

Changes in Doppler‐Derived Kidney Venous Flow and Adverse Cardiorenal Outcomes in Patients With Heart Failure
por: Husain‐Syed, Faeq, et al.
Publicado: (2023)

Right ventricular dyssynchrony: from load-independent right ventricular function to wall stress in severe pulmonary arterial hypertension
por: Richter, Manuel J., et al.
Publicado: (2020)

Mitochondrial Respiration in Peripheral Blood Mononuclear Cells Negatively Correlates with Disease Severity in Pulmonary Arterial Hypertension
por: Sommer, Natascha, et al.
Publicado: (2022)

The Clinical Significance of HbA1c in Operable Chronic Thromboembolic Pulmonary Hypertension
por: Richter, Manuel Jonas, et al.
Publicado: (2016)

Physical Activity and Mental Health of Patients with Pulmonary Hypertension during the COVID-19 Pandemic
por: Dobler, Carolin Leoni, et al.
Publicado: (2020)

Prognostic Relevance of Nonsustained Ventricular Tachycardia in Patients with Pulmonary Hypertension
por: Bandorski, Dirk, et al.
Publicado: (2016)

Fibroblast growth factor 23 as a biomarker of right ventricular dysfunction in pulmonary hypertension
por: Widmann, Laila, et al.
Publicado: (2023)

Inspiratory capacity is not altered in operable chronic thromboembolic pulmonary hypertension
por: Richter, Manuel J., et al.
Publicado: (2017)

Doppler‐Derived Renal Venous Stasis Index in the Prognosis of Right Heart Failure
por: Husain‐Syed, Faeq, et al.
Publicado: (2019)

Circulating Angiopoietin-1 Is Not a Biomarker of Disease Severity or Prognosis in Pulmonary Hypertension
por: Richter, Manuel Jonas, et al.
Publicado: (2016)

Flow rate variance of a fully implantable pump for the delivery of intravenous treprostinil in pulmonary arterial hypertension
por: Richter, Manuel J., et al.
Publicado: (2020)

Survival with sildenafil and inhaled iloprost in a cohort with pulmonary hypertension: an observational study
por: Gall, Henning, et al.
Publicado: (2016)

Decreased plasma levels of the brain-derived neurotrophic factor correlate with right heart congestion in pulmonary arterial hypertension
por: Schäfer, Katharina, et al.
Publicado: (2023)

Against the Odds: Risk Stratification with Cardiac Magnetic Resonance Imaging in Pulmonary Arterial Hypertension
por: Richter, Manuel J., et al.
Publicado: (2020)

Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors
por: Schermuly, Ralph Theo, et al.
Publicado: (2005)

Value of Right and Left Ventricular T1 and T2 Blood Pool Mapping in Patients with Chronic Thromboembolic Hypertension before and after Balloon Pulmonary Angioplasty
por: Roller, Fritz C., et al.
Publicado: (2023)

Evaluation of diagnostic accuracy of dual-energy computed tomography in patients with chronic thromboembolic pulmonary hypertension compared to V/Q-SPECT and pulmonary angiogram
por: Schüssler, Armin, et al.
Publicado: (2023)

Pending Right Heart Failure in Healthy Preterm-Born Subjects?
por: Tello, Khodr, et al.
Publicado: (2020)

Impact of Pulmonary Arterial Hypertension on Employment, Work Productivity, and Quality of Life - Results of a Cross-Sectional Multi-Center Study
por: Fuge, Jan, et al.
Publicado: (2022)

Childhood Trauma in Patients With PAH—Prevalence, Impact on QoL, and Mental Health—A Preliminary Report
por: Park, Da-Hee, et al.
Publicado: (2022)

Impact of SARS-CoV-2-Pandemic on Mental Disorders and Quality of Life in Patients With Pulmonary Arterial Hypertension
por: Park, Da Hee, et al.
Publicado: (2021)

Effects of exercise training on pulmonary hemodynamics, functional capacity and inflammation in pulmonary hypertension
por: Richter, Manuel J., et al.
Publicado: (2017)

Treatment with low-dose tacrolimus inhibits bleeding complications in a patient with hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension
por: Sommer, N, et al.
Publicado: (2018)

Profiles and treatment patterns of patients with pulmonary arterial hypertension on monotherapy at experienced centres
por: Wissmüller, Max, et al.
Publicado: (2022)

Electrophysiological Studies in Patients with Pulmonary Hypertension: A Retrospective Investigation
por: Bandorski, Dirk, et al.
Publicado: (2014)

Air travel can be safe and well tolerated in patients with clinically stable pulmonary hypertension
por: Thamm, Melanie, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ktuugg13a3jod36u773k8sbm15